申请人:Nippon Chemiphar Co., Ltd.
公开号:US04528194A1
公开(公告)日:1985-07-09
A piperazine derivative of the formula: ##STR1## wherein R.sup.1 is a hydrogen atom or a lower alkyl group; R.sup.2 is a hydroxyl group, an aralkyloxy group, a lower alkoxy group containing 1-5 carbon atoms or a lower alkenyloxy group containing 3-5 carbon atoms; R.sup.3 is a hydrogen atom, or an aralkyloxy group, a lower alkoxy group containing 1-5 carbon atoms or a lower alkenyloxy group containing 3-5 carbon atoms; and R.sup.4 is a hydrogen atom or a lower alkoxy group containing 1-5 carbon atoms, provided that R.sup.2 is a group other than the lower alkoxy group containing 1-5 carbon atoms when both R.sup.3 and R.sup.4 are hydrogen atoms; or a pharmaceutically acceptable salt is effectively useful as a cerebral circulation-improving agent.
化合物为哌嗪衍生物,其化学式为:##STR1##其中,R.sup.1为氢原子或低碳基烷基;R.sup.2为羟基、芳基烷氧基、含1-5个碳原子的低碳基烷氧基或含3-5个碳原子的低碳基烯氧基;R.sup.3为氢原子、芳基烷氧基、含1-5个碳原子的低碳基烷氧基或含3-5个碳原子的低碳基烯氧基;R.sup.4为氢原子或含1-5个碳原子的低碳基烷氧基,但当R.sup.3和R.sup.4均为氢原子时,R.sup.2为除含1-5个碳原子的低碳基烷氧基以外的基团;或其药学上可接受的盐可有效用作改善脑循环的药物。